Donor stem cell transplantation associated with survival benefit for patients with leukemia
Wednesday, June 10, 2009 - 02:35
in Health & Medicine
An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT) (stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with nonallogeneic SCT therapies, according to an article in the June 10 issue of JAMA.
Read the whole article on Physorg
More from Physorg
Related
- Donor stem cell transplantation associated with survival benefit for patients with leukemiaTue, 9 Jun 2009, 16:45:18 EDT
- Study IDs benefit of donor SCT for adults with acute myeloid leukemiaTue, 9 Jun 2009, 16:45:12 EDT
- Leukemia stem cells have more in common with embryonic stem cells than adult stem cellsThu, 5 Feb 2009, 12:45:38 EST
- Data presented demonstrate prolonged overall survival for patients with acute myeloid leukemiaWed, 10 Dec 2008, 17:39:36 EST
- Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemiaMon, 6 Jul 2009, 11:29:24 EDT